The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Charlton, Michael
One or more keywords matched the following items that are connected to Charlton, Michael
Item TypeName
Concept Liver Cirrhosis, Experimental
Concept Liver Cirrhosis, Alcoholic
Concept Liver Cirrhosis
Academic Article TT-virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis.
Academic Article Hepatitis G virus infection in patients transplanted for cryptogenic cirrhosis: red flag or red herring?
Academic Article The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population.
Academic Article Interleukin-28B and fibrosing cholestatic hepatitis in posttransplant hepatitis C: a case-control study and literature review.
Academic Article Response to Fibrosis progression in patients treated for hepatitis C recurrence.
Academic Article Liver transplantation for cryptogenic cirrhosis.
Academic Article Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease.
Academic Article Branched chains revisited.
Academic Article Clinical significance of TT virus infection in patients with chronic hepatitis C.
Academic Article Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C.
Academic Article Branched-chain amino acid-enriched supplements as therapy for liver disease: Rasputin lives.
Academic Article Comparative allograft histology after liver transplantation for cryptogenic cirrhosis, alcohol, hepatitis C, and cholestatic liver diseases.
Academic Article Origin of adenocarcinoma in a transplanted liver determined by microsatellite analysis.
Academic Article Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease.
Academic Article Branched-chain amino-acid granules: can they improve survival in patients with liver cirrhosis?
Academic Article Growth hormone, dehydroepiandrosterone and adiponectin levels in non-alcoholic steatohepatitis: an endocrine signature for advanced fibrosis in obese patients.
Academic Article Branched-chain amino acid enriched supplements as therapy for liver disease.
Academic Article Cirrhosis and liver failure in nonalcoholic fatty liver disease: Molehill or mountain?
Academic Article Branched-chain amino acids as pharmacological nutrients in chronic liver disease.
Academic Article Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition.
Academic Article The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.
Academic Article Nutritional status of patients with alcoholic cirrhosis undergoing liver transplantation: time trends and impact on survival.
Academic Article Impact of obesity on treatment of chronic hepatitis C.
Academic Article Insulin resistance, serum adipokines and risk of fibrosis progression in patients transplanted for hepatitis C.
Academic Article Aquaporin-1 facilitates angiogenic invasion in the pathological neovasculature that accompanies cirrhosis.
Academic Article Lumican, an extracellular matrix proteoglycan, is a novel requisite for hepatic fibrosis.
Academic Article Genotype 1b and severity of posttransplant recurrence of hepatitis C infection- unconvictable felon or wrongly accused?
Academic Article Fatty liver and liver transplantation.
Academic Article Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation.
Academic Article Impact of fibrosis progression on clinical outcome in patients treated for post-transplant hepatitis C recurrence.
Academic Article Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes.
Academic Article Noninvasive indices of fibrosis in NAFLD: starting to think about a three-hit (at least) phenomenon.
Academic Article Ultrasound-based transient elastography for the detection of hepatic fibrosis in patients with recurrent hepatitis C virus after liver transplantation: a systematic review and meta-analysis.
Academic Article Neuropilin-1 promotes cirrhosis of the rodent and human liver by enhancing PDGF/TGF-beta signaling in hepatic stellate cells.
Academic Article Treatment of HCV prior to liver transplantation to prevent HCV recurrence - wise or wasteful?
Academic Article Sofosbuvir and Velpatasvir Combination Improves Patient-reported Outcomes for Patients With HCV Infection, Without or With Compensated or Decompensated Cirrhosis.
Academic Article Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis.
Academic Article On-treatment HCV RNA in patients with varying degrees of fibrosis and cirrhosis in the SOLAR-1 trial.
Academic Article Liver Transplantation for Alcoholic and Nonalcoholic Fatty Liver Disease: Pretransplant Selection and Posttransplant Management.
Academic Article Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease.
Academic Article Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.
Academic Article A longitudinal study of whole body, tissue, and cellular physiology in a mouse model of fibrosing NASH with high fidelity to the human condition.
Academic Article Effect of viral suppression on hepatic venous pressure gradient in hepatitis C with cirrhosis and portal hypertension.
Academic Article Patient-reported outcomes with sofosbuvir and velpatasvir with or without ribavirin for hepatitis C virus-related decompensated cirrhosis: an exploratory analysis from the randomised, open-label ASTRAL-4 phase 3 trial.
Academic Article International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Candidates.
Academic Article International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Recipients.
Academic Article Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma.
Academic Article Improvement of hepatic fibrosis and patient-reported outcomes in non-alcoholic steatohepatitis treated with selonsertib.
Academic Article Class III obesity is a risk factor for the development of acute-on-chronic liver failure in patients with decompensated cirrhosis.
Academic Article The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial.
Academic Article GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease.
Academic Article Baseline Factors Associated With Improvements in Decompensated Cirrhosis After Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection.
Academic Article Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis.
Academic Article The Triumph of Bacchus: The Emergence of Nonalcoholic Steatohepatitis and Alcoholic Liver Disease as the Leading Causes of Mortality From Cirrhosis.
Academic Article A randomized, double-blind, multicenter, phase 2b study to evaluate the safety and efficacy of a combination of tropifexor and cenicriviroc in patients with nonalcoholic steatohepatitis and liver fibrosis: Study design of the TANDEM trial.
Academic Article Knockout of sulfatase 2 is associated with decreased steatohepatitis and fibrosis in a mouse model of nonalcoholic fatty liver disease.
Academic Article Efficacy and safety of an orally administered DGAT2 inhibitor alone or coadministered with a liver-targeted ACC inhibitor in adults with non-alcoholic steatohepatitis (NASH): rationale and design of the phase II, dose-ranging, dose-finding, randomised, placebo-controlled MIRNA (Metabolic Interventions to Resolve NASH with fibrosis) study.
Academic Article Liver Transplantation 2023: Status Report, Current and Future Challenges.
Academic Article Clinical characteristics and management of patients with nonalcoholic steatohepatitis in a real-world setting: analysis of the Ipsos NASH therapy monitor database.
Search Criteria
  • Cirrhosis Liver